Bio Pharma Dive
JANUARY 22, 2021
Rather than a once-a-day pill, Cabenuva comes as a once-a-month injection. That convenience could become a valuable tool for GSK as it tries to broaden adoption of two-drug treatments.
NY Times
JANUARY 22, 2021
After the surprise discovery of an extra dose in every vial, Pfizer executives successfully lobbied the F.D.A. to change the vaccine’s formal authorization language. The company charges by the dose.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Bio Pharma Dive
JANUARY 22, 2021
Pricing inclisiran roughly on par with injectable medicines Repatha and Praluent would be cost-effective, an ICER analysis found. But the FDA recently delayed a decision on the Novartis therapy, leaving it in regulatory limbo.
pharmaphorum
JANUARY 22, 2021
Gilead Sciences says its antiviral Veklury should be effective against the new, more contagious COVID-19 variants discovered in the UK and South Africa. According to the US biopharma company, genetic analyses of publicly available sequences for the new variants of SARS-CoV-2 suggest the mutations in the viral spike protein that have made them more transmissible shouldn’t affect the way Veklury (remdesivir) works.
Advertisement
Planning on running clinical trials in Japan? How can you reliably supply these studies? Discover Catalent’s clinical supply packaging facility in Shiga, Japan. Strategically located between Tokyo and Osaka, and one of largest in Japan, this 6,000 square meter facility offers comprehensive services including primary and secondary clinical packaging and labelling, comparator sourcing, cold chain storage, local and global distribution, local language support and white glove service to support stud
BioPharma Reporter
JANUARY 22, 2021
The World Health Organizationâs Global Advisory Committee on Vaccine Safety says it has not seen any unexpected or untoward increase in fatalities in frail and elderly individuals who have received the Pfizer/BioNTech vaccine.
pharmaphorum
JANUARY 22, 2021
The ongoing COVID-19 pandemic has affected the routines of many practicing physicians, including an impact on their prescribing decisions. New research from CRA shows that for many physician practices, prescribing has shifted based on route of administration. These changes, initially presumed to be temporary, may continue beyond the pandemic. As several COVID-19 vaccine candidates progress to patients and with more than 150 other vaccines in clinical development, global communities look forward
Clinical Research Informer brings together the best content for clinical researchers from the widest variety of industry thought leaders.
pharmaphorum
JANUARY 22, 2021
NICE has said that the NHS should not fund Bristol-Myers Squibb’s multiple sclerosis pill Zeposia (ozanimod) for relapsing multiple sclerosis in first draft guidance. The cost-effectiveness body said that trial evidence showed Zeposia cuts the number of relapses and brain lesions compared with Biogen’s Avonex (interferon beta-1a). But in its first draft guidance NICE said that Zeposia’s effect on progression of disability is unclear.
Scienmag
JANUARY 22, 2021
Understanding previously undocumented source of new particle formation will improve models of aerosols, clouds, and their impact on Earth’s climate Credit: Image courtesy of the U.S. Department of Energy Atmospheric Radiation Measurement (ARM) user facility. UPTON, NY – New results from an atmospheric study over the Eastern North Atlantic reveal that tiny aerosol particles that […].
Pharma Times
JANUARY 22, 2021
Company has completed genetic analysis for UK and South African variants
Scienmag
JANUARY 22, 2021
Physicists from Göttingen first to succeed in filming a phase transition with extremely high spatial and temporal resolution Credit: Dr Murat Sivis Laser beams can be used to change the properties of materials in an extremely precise way. This principle is already widely used in technologies such as rewritable DVDs. However, the underlying processes generally […].
Advertisement
White paper that delves into the complex topic of Decentralized Clinical Trials and how to master them within the confines of FDA Regulations
Pharma Times
JANUARY 22, 2021
Cost-effectiveness estimates 'uncertain', according to NICE
Scienmag
JANUARY 22, 2021
Credit: RUDN University A professor from RUDN University together with his Indian colleagues synthesized and studied new dibenzophenazine-based liquid crystals that could potentially be used in optoelectronics and solar panels. The results of the study were published in the Journal of Molecular Liquids. Liquid crystals are an intermediate phase between a liquid and a solid […].
pharmaphorum
JANUARY 22, 2021
Research Partnership’s Emilie Braund and Harrison Gaiger dig down into the top insights pharma companies can harness to make their patient support programmes as powerful as possible. The pandemic has undoubtedly disrupted the healthcare landscape and amplified the complex factors that influence and shape patient journeys. Findings from our recently published whitepaper ‘Free thinking: The impact of COVID-19 on chronic disease management and the implications for pharma marketing’ revealed that, i
Scienmag
JANUARY 22, 2021
Cryo-electron microscopy study allows researchers to visualize structural changes in an E. coli enzyme synthesizing ribosomal RNA that shift it between turbo- and slow-modes depending on the bacteria’s growth rate Credit: Murakami Laboratory, Penn State The enzyme that makes RNA from a DNA template is altered to slow the production of ribosomal RNA (rRNA), the […].
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Pharma Times
JANUARY 22, 2021
Companies will develop saRNA therapies to treat neurological diseases
Scienmag
JANUARY 22, 2021
Credit: RUDN University A professor from RUDN University together with his colleagues from Saratov Chernyshevsky State University and D. Mendeleev University of Chemical Technology of Russia developed a method for calculating the parameters of diffraction optical elements used in LCDs. In particular, the new technology can be used to expand the angle of view while […].
Delveinsight
JANUARY 22, 2021
The launch of a novel drug in the market is not less than a celebration in the pharmaceutical and healthcare market; however, it also brings the real challenge of sustenance in the market. Similar is the picture of the Thrombocytopenia Drugs Market. Thrombocytopenia pipeline possesses potential drugs in mid-stage developments to be approved shortly.
Scienmag
JANUARY 22, 2021
The U.S. Department of Energy recently announced $8.7 million in awards to “Develop Emerging Carbon-Based Building and Construction Materials,” with OHIO’s Jason Trembly receiving two $500,000 grants for two separate projects focused on addressing climate change and sustainability issues surrounding construction and infrastructure.
Advertisement
This new white paper defines and details the impact of Decentralized Clinical Trials on the Pharmaceutical industry and how the impact can be measured along with steps companies can take to ensure adoption.
Pharma Times
JANUARY 22, 2021
Cabenuva consists of ViiV Healthcare’s cabotegravir and Janssen’s rilpivirine
Scienmag
JANUARY 22, 2021
Human papillomavirus (HPV) is the most common sexually transmitted infection, with an estimated 79 million Americans currently infected with the virus, according to the Centers for Disease Control and Prevention. If a high-risk HPV infection does not go away, it can lead to the development of a variety of cancers, including 91% of all cervical […].
XTalks
JANUARY 22, 2021
Vancouver, Canada-based Modern Meat announced the planned acquisition of plant-based soup company Kitskicthen Health Foods , further expanding its plant-based portfolio. Kitskitchen will join Modern Meat’s line of 100 percent vegan, GMO-free meat alternatives and its newest line of dairy alternative milk , featuring Oat M*lk, Almond M*lk and Barista Edition Alternative M*lk.
Scienmag
JANUARY 22, 2021
Study found an approved drug could make radiation therapy more effective Credit: Colleen Kelley/University of Cincinnati Head and neck cancer is the sixth most common cancer worldwide, and while effective treatments exist, sadly, the cancer often returns. Researchers at the University of Cincinnati have tested a new combination therapy in animal models to see if […].
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
pharmaphorum
JANUARY 22, 2021
It’s evident that relying on Google for a health diagnosis isn’t a good idea, but it seems a majority of UK people still do – and even buy medicines based on what they find. A new UK survey finds that overall 59% of 1,000 respondents Google their health symptom before consulting a doctor, with 16% reporting that as a consequence a condition has gone undiagnosed by a doctor for some time.
Scienmag
JANUARY 22, 2021
Nearly pain-free microneedle patch can test for antibodies and more in the fluid between cells Credit: Image: Sisi Cao Blood draws are no fun. They hurt. Veins can burst, or even roll — like they’re trying to avoid the needle, too. Oftentimes, doctors use blood samples to check for biomarkers of disease: antibodies that signal […].
NY Times
JANUARY 22, 2021
Seeking to secure vital supplies, the authorities in the country maneuvered around anticorruption rules that require public disclosure of contracts.
Scienmag
JANUARY 22, 2021
Credit: NASA image courtesy Jeff Williams Predictions of future climate change require a clear and nuanced understanding of Earth’s past climate. In a study published today in Science Advances, University of Hawai’i (UH) at M?noa oceanographers fully reconciled climate and carbon cycle trends of the past 50 million years–solving a controversy debated in the scientific […].
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
The Pharma Data
JANUARY 22, 2021
NEW YORK , Jan. 22, 2021 /PRNewswire/ — The Lupus Research Alliance (LRA) is excited to share that the U.S. Food and Drug Administration (FDA) approved the use of Aurinia Pharmaceuticals’ Lupkynis TM (voclosporin) as the first oral treatment developed specifically for adults with active lupus nephritis (LN) in combination with standard of care.
Scienmag
JANUARY 22, 2021
James Nestor joins American Rhinologic Society to launch sinushealth.com, first-ever patient-focused online resource dedicated to nasal and sinus conditions and treatments powered by experts from the American Rhinologic Society WHAT: Chronic sinusitis is a major health problem, impacting 30 million Americans. For more than 65 years, the American Rhinologic Society (ARS) has promoted excellence in […].
Drug Patent Watch
JANUARY 22, 2021
Annual Drug Patent Expirations for INLYTA Inlyta is a drug marketed by Pf Prism Cv and is included in one NDA. It is available from two suppliers. There are four…. The post New patent for Pf Prism drug INLYTA appeared first on DrugPatentWatch - Make Better Decisions.
Scienmag
JANUARY 22, 2021
Credit: Chen Lab / Brown University PROVIDENCE, R.I. [Brown University] — Metallurgists have all kinds of ways to make a chunk of metal harder. They can bend it, twist it, run it between two rollers or pound it with a hammer. These methods work by breaking up the metal’s grain structure — the microscopic crystalline […].
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
Expert insights. Personalized for you.
246 
Let's personalize your content